OneMedNet Secures $3.7 Million in Private Placement Funding
OneMedNet Corporation, a leader in regulatory-grade imaging Real-World Data, has successfully engaged in private placement transactions resulting in approximately $3.7 million in gross proceeds. The private placements were conducted with accredited investors at a share price of $0.42, which aligns with Nasdaq's minimum price requirement.
Strategic Use of Funds
The funds raised through this private placement will be utilized for essential working capital and other corporate purposes, allowing OneMedNet to enhance its operational capabilities. Though the transactions closed around June 19, 2025, the focus remains on advancing the company’s technological innovations.
Strengthening Financial Stability
In the ongoing effort to bolster its financial stability, OneMedNet has also undertaken significant measures to reduce liabilities. Recently, the Company executed a strategy to address roughly $11 million in current liabilities, marking a remarkable 60% decrease from the total liabilities recorded earlier this year.
Key Financial Steps Taken
- Settled approximately $3.26 million related to deferred underwriter fees associated with a prior business combination.
- Paid off about $1.08 million in trade payables and other outstanding amounts.
- Converted around $6.56 million in principal and interest from noteholders into common stock.
- Redeemed $250,000 from a prior convertible promissory note.
About OneMedNet Corporation
OneMedNet is at the forefront of transforming access to Real-World Data, leveraging its innovative iRWD™ platform, which connects over 1,400 healthcare sites. This platform not only facilitates enhanced patient care but also drives significant advancements across various sectors, including pharmaceuticals, medical devices, and artificial intelligence. OneMedNet’s holistic approach enables a breadth of possibilities, making it a valuable entity in the healthcare technology landscape.
Versatility Across Industries
Beyond healthcare, the Company’s proprietary AI technology extends its reach to other industries such as finance, retail, and telecommunications. This versatility adds a layer of flexibility, ensuring that sensitive data can be securely shared while being anonymized, thus opening doors for new innovations and efficiencies.
Looking Ahead
With the recent influx of capital and significant liability reductions, OneMedNet is well-positioned to pursue its ambitious goals. The Company remains committed to harnessing the power of Real-World Data not only to improve healthcare outcomes but also to make meaningful strides in other industries where data plays a crucial role.
Frequently Asked Questions
What recent funding activity has OneMedNet completed?
OneMedNet recently secured $3.7 million through private placement transactions involving accredited investors.
How does OneMedNet plan to use the new funding?
The funding will be allocated for working capital and general corporate purposes to bolster the company's operations.
What financial measures has OneMedNet taken to enhance its stability?
The company has reduced approximately $11 million in liabilities, achieving a significant 60% decrease in total financial obligations.
What is OneMedNet’s iRWD™ platform?
The iRWD™ platform allows for the collection and use of regulatory-grade Real-World Data from various healthcare sites, improving insights and outcomes.
In which other industries is OneMedNet’s data technology applied?
OneMedNet's AI technology is adaptable and is used across finance, retail, and telecommunications, demonstrating its broad applicability and potential for innovation.
